| # | Drug | Count |
|---|---|---|
| 0 | ALIROCUMAB | 85 |
| 1 | APIXABAN | 12 |
| 2 | BISOPROLOL FUMARATE | 12 |
| 3 | EMPAGLIFLOZIN | 7 |
| 4 | ASPIRIN | 6 |
| 5 | HYDROCHLOROTHIAZIDE | 6 |
| 6 | INSULIN GLARGINE | 6 |
| 7 | ORAL SEMAGLUTIDE | 6 |
| 8 | SIMVASTATIN | 6 |
| 9 | ASPIRIN 325 MG | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM SULFACETAMIDE | 1 | 0.0055 |
| 1 | ALIROCUMAB | 85 | 0.0033 |
| 2 | RIVASTIGMINE TARTRATE | 1 | 0.0022 |
| 3 | SULFACETAMIDE SODIUM | 1 | 0.0020 |
| 4 | GARADACIMAB | 1 | 0.0013 |
| 5 | RILONACEPT | 1 | 0.0009 |
| 6 | GADOTERATE MEGLUMINE | 3 | 0.0008 |
| 7 | SENNA LAXATIVE | 1 | 0.0008 |
| 8 | STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM | 1 | 0.0007 |
| 9 | MOMELOTINIB | 1 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | PCSK9 Inhibitor [EPC] | 86 | 0.0033 |
| 1 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 2 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |
| 3 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 4 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Cholinesterase Inhibitor [EPC] | 3 | 0.0002 |
| 6 | Cannabinoid [EPC] | 1 | 0.0001 |
| 7 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 8 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 9 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 7 | 0.0001 |